WHO Estimated The Cost Of Developing Vaccines And Treatment For Coronavirus At $31 Billion
Accelerated development and production of coronavirus vaccines and drugs (COVID-19), as well as testing methods, will require an investment of approximately $31 billion in the near future.
According to the statement, "the cost plan presented today provides funding of $31.3 billion." At the same time, the WHO clarified that $3.4 billion has already been received, but in the next 12 months, another $27.9 billion will be required, including $14 billion for urgent needs.
At an online briefing, the special representative of this project, Ngozi Okonjo-Iweala, stressed that these funds would definitely pay off.
"Although these numbers look large, this is not the case when we think about an alternative. If we spend billions now, we will avoid spending trillions later," she said.
The media notes that the funds requested for the project should make it possible to conduct 500 million tests for coronavirus in low-and middle-income countries by mid-2021, as well as to implement 245 million courses of treatment there. It is also expected that by the end of 2021, 2 billion doses of vaccines will be distributed, half of them in low-and middle-income countries.
In turn, the head of WHO Tedros Adhanom Ghebreyesus pointed out that the key principle in this initiative is equal access for all to treatment and vaccination. According to him, "for real effectiveness, they (treatment methods) must be prescribed with another essential ingredient - solidarity."
According to the statistics website Worldometer, more than 9.7 million cases of COVID-19 have been detected worldwide. More than 492 thousand infected people died, and more than 5.2 million people recovered.